ATE479680T1 - Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs - Google Patents
Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebsInfo
- Publication number
- ATE479680T1 ATE479680T1 AT07855058T AT07855058T ATE479680T1 AT E479680 T1 ATE479680 T1 AT E479680T1 AT 07855058 T AT07855058 T AT 07855058T AT 07855058 T AT07855058 T AT 07855058T AT E479680 T1 ATE479680 T1 AT E479680T1
- Authority
- AT
- Austria
- Prior art keywords
- hydrogen
- halo
- imidazolidinonylaminopyrimidine
- compounds
- methyl
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- IDNYTLARUCTDGK-UHFFFAOYSA-N 1-(pyrimidin-2-ylamino)imidazolidin-2-one Chemical class N1(C(NCC1)=O)NC1=NC=CC=N1 IDNYTLARUCTDGK-UHFFFAOYSA-N 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 125000001475 halogen functional group Chemical group 0.000 abstract 5
- 150000002431 hydrogen Chemical class 0.000 abstract 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 3
- VLUNZXPZDFIDHY-UHFFFAOYSA-N 1-(2-aminopyrimidin-4-yl)imidazolidin-2-one Chemical class NC1=NC=CC(N2C(NCC2)=O)=N1 VLUNZXPZDFIDHY-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 abstract 1
- 108010056274 polo-like kinase 1 Proteins 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87130206P | 2006-12-21 | 2006-12-21 | |
| PCT/US2007/087044 WO2008076704A1 (en) | 2006-12-21 | 2007-12-11 | Imidazolidinonyl aminopyrimidine compounds for the treatment' of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE479680T1 true ATE479680T1 (de) | 2010-09-15 |
Family
ID=39186811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07855058T ATE479680T1 (de) | 2006-12-21 | 2007-12-11 | Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8101628B2 (enExample) |
| EP (1) | EP2125793B1 (enExample) |
| JP (1) | JP5166441B2 (enExample) |
| KR (1) | KR101088291B1 (enExample) |
| CN (1) | CN101563342B (enExample) |
| AT (1) | ATE479680T1 (enExample) |
| AU (1) | AU2007334039B2 (enExample) |
| BR (1) | BRPI0721045A2 (enExample) |
| CA (1) | CA2671738A1 (enExample) |
| DE (1) | DE602007008952D1 (enExample) |
| EA (1) | EA016177B1 (enExample) |
| ES (1) | ES2349169T3 (enExample) |
| MX (1) | MX2009006634A (enExample) |
| WO (1) | WO2008076704A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA016178B1 (ru) | 2006-12-21 | 2012-02-28 | Эли Лилли Энд Компани | Соединения имидазолидинониламинопиримидина |
| EP2155735A2 (en) | 2007-05-16 | 2010-02-24 | Eli Lilly And Company | Triazolyl aminopyrimidine compounds |
| TW200908981A (en) * | 2007-05-16 | 2009-03-01 | Lilly Co Eli | Triazolyl aminopyrimidine compounds |
| CN108853111B (zh) * | 2018-08-07 | 2020-06-05 | 浙江大学 | 一种组合物在制备治疗吉非替尼肝脏毒性药物中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4929726A (en) | 1988-02-09 | 1990-05-29 | Georgia State University Foundation, Inc. | Novel diazines and their method of preparation |
| US6939877B2 (en) * | 2002-09-12 | 2005-09-06 | Wyeth | Antidepressant piperidine derivatives of heterocycle-fused benzodioxans |
| WO2004063192A1 (en) * | 2003-01-10 | 2004-07-29 | Pharmacopeia Drug Discovery, Inc. | Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators |
| GB0308466D0 (en) | 2003-04-11 | 2003-05-21 | Novartis Ag | Organic compounds |
| WO2005012283A1 (en) * | 2003-07-31 | 2005-02-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted benzothiophene compounds and uses thereof |
| CN101115749B (zh) * | 2004-12-17 | 2011-06-22 | 安姆根有限公司 | 氨基嘧啶化合物和使用方法 |
| TW200800201A (en) * | 2005-11-18 | 2008-01-01 | Lilly Co Eli | Pyrimidinyl benzothiophene compounds |
| EP2001480A4 (en) * | 2006-03-31 | 2011-06-15 | Abbott Lab | Indazole CONNECTIONS |
| EA016178B1 (ru) | 2006-12-21 | 2012-02-28 | Эли Лилли Энд Компани | Соединения имидазолидинониламинопиримидина |
| EP2155735A2 (en) | 2007-05-16 | 2010-02-24 | Eli Lilly And Company | Triazolyl aminopyrimidine compounds |
| TW200908981A (en) | 2007-05-16 | 2009-03-01 | Lilly Co Eli | Triazolyl aminopyrimidine compounds |
-
2007
- 2007-12-11 AT AT07855058T patent/ATE479680T1/de not_active IP Right Cessation
- 2007-12-11 BR BRPI0721045-0A patent/BRPI0721045A2/pt not_active IP Right Cessation
- 2007-12-11 CN CN2007800472640A patent/CN101563342B/zh not_active Expired - Fee Related
- 2007-12-11 EP EP07855058A patent/EP2125793B1/en not_active Not-in-force
- 2007-12-11 US US12/516,514 patent/US8101628B2/en not_active Expired - Fee Related
- 2007-12-11 JP JP2009543061A patent/JP5166441B2/ja not_active Expired - Fee Related
- 2007-12-11 WO PCT/US2007/087044 patent/WO2008076704A1/en not_active Ceased
- 2007-12-11 CA CA002671738A patent/CA2671738A1/en not_active Abandoned
- 2007-12-11 MX MX2009006634A patent/MX2009006634A/es active IP Right Grant
- 2007-12-11 KR KR1020097012835A patent/KR101088291B1/ko not_active Expired - Fee Related
- 2007-12-11 ES ES07855058T patent/ES2349169T3/es active Active
- 2007-12-11 DE DE602007008952T patent/DE602007008952D1/de active Active
- 2007-12-11 AU AU2007334039A patent/AU2007334039B2/en not_active Ceased
- 2007-12-11 EA EA200970615A patent/EA016177B1/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN101563342A (zh) | 2009-10-21 |
| CN101563342B (zh) | 2012-09-05 |
| US8101628B2 (en) | 2012-01-24 |
| US20100076001A1 (en) | 2010-03-25 |
| ES2349169T3 (es) | 2010-12-28 |
| EA016177B1 (ru) | 2012-02-28 |
| EA200970615A1 (ru) | 2009-10-30 |
| JP5166441B2 (ja) | 2013-03-21 |
| KR101088291B1 (ko) | 2011-11-30 |
| AU2007334039A1 (en) | 2008-06-26 |
| WO2008076704A1 (en) | 2008-06-26 |
| AU2007334039B2 (en) | 2012-02-16 |
| DE602007008952D1 (de) | 2010-10-14 |
| BRPI0721045A2 (pt) | 2014-07-29 |
| JP2010513552A (ja) | 2010-04-30 |
| EP2125793B1 (en) | 2010-09-01 |
| MX2009006634A (es) | 2009-06-30 |
| EP2125793A1 (en) | 2009-12-02 |
| CA2671738A1 (en) | 2008-06-26 |
| KR20090086114A (ko) | 2009-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0510177B8 (pt) | composto, composição farmacêutica e uso do mesmo | |
| JO3007B1 (ar) | مركبات و تركيبات كمثبطات كيناز بروتين | |
| EA201000100A1 (ru) | Гетероциклические соединения, полезные в качестве ингибиторов mk2 | |
| CY1110900T1 (el) | Χημικες ενωσεις | |
| CY1108275T1 (el) | Χημικες ενωσεις | |
| MXPA05012061A (es) | Preparacion y uso de derivados alquilarilo para el tratamiento de la obesidad. | |
| GEP20084551B (en) | 4-phenylamino-quinazolin-6-yl-amides | |
| TW200716606A (en) | Chemical compounds | |
| TW200800963A (en) | Chemical compounds | |
| IL182218A0 (en) | Preparation and use of biphenyl-4-yl-carbonylamino and derivatives for the treatment of obesity | |
| EA200900023A1 (ru) | Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли | |
| TW200728305A (en) | Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease | |
| SG170101A1 (en) | 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. | |
| EA200802223A1 (ru) | 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90 | |
| MY149512A (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
| DE602007001463D1 (de) | Pyrimidin-, chinazolin-, pteridin- und triazinderivate | |
| EA200870577A1 (ru) | Конденсированные трициклические сульфонамидные ингибиторы гамма-секретазы | |
| ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| EA201170344A1 (ru) | Азаиндольные ингибиторы iap | |
| DE602007011434D1 (de) | 1h-indol-5-ylpiperazin-1-ylmethanonderivate | |
| MY158069A (en) | Tricyclic compound and pharmaceutical use thereof | |
| TW200716547A (en) | Piperidin-4-yl-amide derivatives | |
| ATE479680T1 (de) | Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs | |
| TW200639155A (en) | Thiazolidinones, their production and use as pharmaceutical agents | |
| ATE485291T1 (de) | Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |